Tune in to this enduring recording of the live satellite symposium from the 2024 ASH Annual Meeting and Exposition as our expert faculty take a deep dive into the latest clinical evidence and practical considerations for treatment of complex cases of patients with multiple myeloma (MM). Informed by real-world data on challenges regarding selection and sequencing of treatment plans and coordinating MM care, highlighting differences stemming from practice setting, our expert panelists will participate in insightful discussions regarding benefits and risks of different treatment options. Based on the latest clinical data and patient characteristics, discussions will include different perspectives and institutional differences, with supportive slides featuring the current clinical evidence and strategies for integrating the best treatments for individual patients into treatment plans, emphasizing nuances between academic- and community-based settings. Topics will be supported by clinical cases and enhanced by interactive polling questions and live questions submitted by attendees throughout the presentation. Don’t miss this opportunity to hear expert faculty harness real-world experiences providing MM care to deepen the impact of the education to enhance treatment selection and care coordination for the optimal integration of novel therapies in MM across practice settings in this exciting satellite symposium.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/accelerating-adoption-latest-evidence-sequencing-therapies-multiple-myeloma
- Start Date: 2024-12-30 06:00:00
- End Date: 2024-12-30 06:00:00
- Credit Details: IPCE Credits: 1.5 hours
AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Karyopharm - Amount: 25000.0 - Is Kind Support: False Source: Legend Biotech USA Inc. - Amount: 14500.0 - Is Kind Support: False Source: Sanofi S.A. - Amount: 62500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology